OTC Cough, Cold and Allergy Medicine Market to Register Exponential Compound Annual Growth Rate Through 2025
Market Overview: Over the cough are the products which are used to relieve symptoms of cold, flu, and allergy, including nasal stuffiness and congestion, sneezing, runny noses, sore throat, and cough. The main causes of these symptoms are common cold, influenza virus, allergic rhinitis, fever and sinus infections. Global OTC Cough, Cold & Allergy Medicine Market is expected to grow in the forecasted period, in 2017 market size of the OTC Cough, Cold & Allergy Medicine was XX million and in 2025 is expected to reach at XX million with growing CAGR of XX%.
Market Overview:
Over the cough are the products which are used to relieve symptoms of cold, flu, and allergy, including nasal stuffiness and congestion, sneezing, runny noses, sore throat, and cough. The main causes of these symptoms are common cold, influenza virus, allergic rhinitis, fever and sinus infections. Global OTC Cough, Cold & Allergy Medicine Market is expected to grow in the forecasted period, in 2017 market size of the OTC Cough, Cold & Allergy Medicine was XX million and in 2025 is expected to reach at XX million with growing CAGR of XX%.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REPORT DESCRIPTION<br />
<strong>Market</strong> Overview:<br />
Over the cough are the products which are used <strong>to</strong> relieve symp<strong>to</strong>ms of cold, flu, <strong>and</strong> allergy, including nasal stuffiness <strong>and</strong> congestion, sneezing,<br />
runny noses, sore throat, <strong>and</strong> cough. The main causes of these symp<strong>to</strong>ms are common cold, influenza virus, allergic rhinitis, fever <strong>and</strong> sinus<br />
infections. Global <strong>OTC</strong> <strong>Cough</strong>, <strong>Cold</strong> & <strong>Allergy</strong> <strong>Medicine</strong> <strong>Market</strong> is expected <strong>to</strong> grow in the forecasted period, in 2017 market size of the <strong>OTC</strong><br />
<strong>Cough</strong>, <strong>Cold</strong> & <strong>Allergy</strong> <strong>Medicine</strong> was XX million <strong>and</strong> in <strong>2025</strong> is expected <strong>to</strong> reach at XX million with growing CAGR of XX%.<br />
<strong>Market</strong> Dynamics:<br />
Fac<strong>to</strong>r such as government initiatives, better healthcare facilities <strong>and</strong> increasing number of immunosuppressed individuals which are expected<br />
<strong>to</strong> boost the growth of the <strong>OTC</strong> <strong>Cough</strong>, <strong>Cold</strong> & <strong>Allergy</strong> <strong>Medicine</strong> <strong>Market</strong>. Furthermore, rising global geriatric population, laws enforcing consumer<br />
safety <strong>and</strong> increasing usage of cold & cough medications for minor issues is expected <strong>to</strong> boost the growth of the overall market. However, costs<br />
& prices with manufacturing process of the product are expected <strong>to</strong> hinder the growth of the <strong>OTC</strong> <strong>Cough</strong>, <strong>Cold</strong> & <strong>Allergy</strong> <strong>Medicine</strong> <strong>Market</strong> over<br />
the forecast period.<br />
Get More Information About-Global <strong>OTC</strong> <strong>Cough</strong>, <strong>Cold</strong> <strong>and</strong> <strong>Allergy</strong> <strong>Medicine</strong><br />
<strong>Market</strong>: https://www.trendsmarketresearch.com/report/sample/3243<br />
<strong>Market</strong> Players:<br />
Sanofi-Aventis, Johnson & Johnson Service, Inc., Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZaneca Plc.,<br />
Pfizer Inc., Sun Pharmaceutical Industries Ltd., Prestige Br<strong>and</strong>s Holdings, Inc., Procter & Gamble Co., Bris<strong>to</strong>l-Myers Squib Co., Merck &<br />
Co., <strong>and</strong> Allergenare some of the prominent players in the <strong>OTC</strong> <strong>Cough</strong>, <strong>Cold</strong> & <strong>Allergy</strong> <strong>Medicine</strong> <strong>Market</strong>.<br />
<strong>Market</strong> Segmentation:<br />
Asia-Pacific expected <strong>to</strong> grow with a fastest CAGR over forecast period majorly due <strong>to</strong> government initiatives, dropping air quality which results<br />
in increase in pollution <strong>and</strong> higher occurrence of respira<strong>to</strong>ry ailments. Furthermore, rapid adoption of <strong>OTC</strong> medicines convenience of purchase<br />
<strong>and</strong> cost-efficiency is also expected <strong>to</strong> boost the growth of the overall market in this region. Countries such as China <strong>and</strong> Japan are expected <strong>to</strong><br />
account for the largest market share over the forecast period.<br />
Pharmacies segment of sales channel dominated the market in 2017 majorly due <strong>to</strong> increasing sales of allergy, cold & cough drugs.
Change language